Joseph C Larson

Mr. Joseph C Larson

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Menopause
Verified
Journal Article
Open access
HJHadine Joffe
Hadine Joffe
KGKatherine A. Guthrie
Katherine A. Guthrie
JLJoseph C Larson
Joseph C Larson
LCLee S. Cohen
Lee S. Cohen
JCJanet S. Carpenter
Janet S. Carpenter
EFEllen W. Freeman
Ellen W. Freeman
Vasomotor symptoms (VMS) recur after discontinuation of hormonal therapy. Selective serotonin reuptake inhibitors (SSRIs) are used increasingly to treat VMS, but whether VMS recur after cessation of SSRI is unknown. We hypothesized that relapse of VMS to baseline levels after SSRI cessation would be common and predicted by menopausal and psychological characteristics. Recurrence of VMS (frequency, severity, and bother) was measured with daily diaries for 3 weeks after cessation of escitalopram, which was administered to perimenopausal/postmenopausal women with hot flashes and night sweats in an 8-week randomized, placebo-controlled trial. Blinding of staff and participants was maintained throughout. Relapse was defined as mean daily VMS frequency, severity, or bother 20% or less lower than pretreatment levels. Of 76, 57, and 51 women included in the analysis for VMS frequency, severity, and bother, 34.2%, 38.6%, and 37.3%, respectively, had relapse of VMS frequency, severity, and bother. In adjusted models, VMS frequency relapse was predicted by higher levels of pretreatment insomnia symptoms (P = 0.02) and a weaker response to escitalopram (P = 0.03). Among women whose VMS improved with escitalopram, approximately one third relapsed swiftly after discontinuation of the medication. Those with pretreatment insomnia and those with a weaker response to escitalopram may be at greatest risk for VMS relapse after treatment discontinuation. Women should be educated about the likelihood of VMS symptom relapse when they discontinue SSRIs after receiving benefits from short-term treatment.

24 February 2021 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
TBTheodore M. Brasky
Theodore M. Brasky
KFKatrina F. Flores
Katrina F. Flores
JLJoseph C Larson
Joseph C Larson
ANAlison M. Newton
Alison M. Newton
ASAladdin H. Shadyab
Aladdin H. Shadyab
ALAndrea Z. LaCroix
Andrea Z. LaCroix
Background: Use of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) has been postulated to reduce cancer risk by inhibition of tumor progression, vascularization, and metastasis. The renin–angiotensin system is upregulated in colorectal cancers; however, the association of ACEi and ARB use with colorectal cancer risk is not well understood. Methods: The study population was 142,812 Women's Health Initiative participants free of colorectal cancer who reported on ACEi and ARB use at baseline; 2,216 incident colorectal cancers were diagnosed during 10 years of follow-up. Cox regression models estimated adjusted HRs and 95% confidence intervals for associations relative to nonuse among normotensive women, untreated hypertensive women, and hypertensive women treated with other antihypertensive medications. Results: HRs among women who used any ACEi or ARB compared with nonuse in the three referent groups ranged between 0.97 and 1.01. Findings were similar for increased ACEi/ARB duration and for medications examined as separate classes or individually. Conclusions: In this large prospective study of women, no associations of ACEi or ARB use with colorectal cancer risk were observed. Impact: Choice of drug in the large population of aging women who will be prescribed ACEi and ARB should be made without factoring in any benefit on colorectal cancer risk.

4 April 2025 in Kidney360
Verified
Journal Article
Open access
TJTanya S. Johns
Tanya S. Johns
MEMichelle M. Estrella
Michelle M. Estrella
JHJames Hebert
James Hebert
NFNora Franceschini
Nora Franceschini
JLJoseph C Larson
Joseph C Larson
MMMichal L. Melamed
Michal L. Melamed
Key Points: A pro-inflammatory diet was associated with a higher risk of incident kidney failure. Clinical trials should assess the impact of an anti-inflammatory dietary pattern on CKD risk and progression. Background: Diet affects inflammation and kidney health, but few studies have investigated dietary inflammatory potential in CKD progression, particularly in women. We aim to examine this association in the Women's Health Initiative. Methods: We conducted a nonconcurrent prospective cohort study among Women's Health Initiative participants enrolled in the clinical trials and observational study (1993–1998) without baseline CKD and with available dietary intake assessments, Medicare data, and creatinine measurements at enrollment. The inflammatory potential of diets was assessed using the dietary inflammatory index, an acultural tool that quantifies diets from anti-inflammatory to proinflammatory. Scores were categorized into quartiles, with Q1 (reference group) and Q4 indicating the least and most inflammatory diets, respectively. Incident kidney failure (CKD stage G5, ESKD, or transplantation) was identified using diagnosis codes in Medicare claims from enrollment through December 31, 2019. We performed multivariable Cox proportional hazards regression and modeled death as a competing risk to determine the risk of incident kidney failure. Results: Among the 17,334 women included in our study, the baseline mean age was 64.9 years (standard deviation 7.1); 33.5% self-identified as Black, 8.8% as Hispanic, 38% had hypertension, and 6.8% had diabetes mellitus. The baseline mean eGFR was 87.2 ml/min per 1.73 m2. Over a mean follow-up of 11.2 years, 1852 women (10.7%) developed kidney failure. Compared with Q1, women with dietary patterns in Q4 had a 18% higher risk (95% confidence interval, 1.03 to 1.37; P trend = 0.01) of developing kidney failure after adjusting for age, race and ethnicity, education, region, comorbidities, medications, smoking, energy intake, physical activity, eGFR, and body mass index. Competing risk models yielded similar results. Conclusions: A proinflammatory diet (e.g., enriched in processed foods, refined sugars, and red meat) was associated with incident kidney failure in postmenopausal women without baseline CKD. Clinical trials are needed to assess the effect of an anti-inflammatory dietary pattern on CKD risk and progression.

9 December 2025 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
SWSylvia Wassertheil-Smoller
Sylvia Wassertheil-Smoller
JLJoseph C Larson
Joseph C Larson
XXXionan Xue
Xionan Xue
RGRuby Greywoode
Ruby Greywoode
MBMicheal Böhm
Micheal Böhm
MLMichael J. LaMonte
Michael J. LaMonte
INTRODUCTION: To identify risk and protective factors in older women for incidence of ischemic colitis (IC) and 30-day mortality. METHODS: We conducted a prospective study of 100,825 women in the Women's Health Initiative, with an average of 13.1-year follow-up and extensive phenotypic and outcomes data in diverse race and ethnic groups. Lasso Cox regression selected variables related to incidence of IC from multiple domains (demographic, comorbidities, risk factors, biomarkers, psychosocial factors, and dietary factors). Cox regressions modelled the selected variables to obtain adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs). RESULTS: The incidence rate of IC was twice as high among those with a history of cardiovascular disease (55.7 per 10,000 person-years) compared with those with no such history (27.3 per 10,000 person-years). After adjustment for multiple covariates, higher risk was associated with diastolic blood pressure below 90 mm Hg, using 2 or more types of antihypertensive medications compared with none (aHR 1.62, 95% CI 1.47–1.78), having gastrointestinal symptoms (aHR 1.31, 95% CI 1.20–1.42 highest vs lowest quartile). Higher fiber intake was associated with lower risk (aHR per increase of 10 g/d 0.93, 95% CI 0.89–0.97), and Black women had lower adjusted risk of IC than White women (aHR 0.73, 95% CI 0.63–0.83). Post-IC 30-day all-cause mortality was 10.6%, and sepsis was an important cause of death. DISCUSSION: The incidence rate of IC in older women was twice as high in those with a history of cardiovascular disease and was associated with low diastolic blood pressure and multiclass antihypertensive treatment. Dietary fiber intake was associated with lower risk. Black women had lower risk of IC compared with White women.

6 May 2026 in Diabetology
Verified
Journal Article
Open access
PDF file
AGAndrea Glenn
Andrea Glenn
JLJoseph C Larson
Joseph C Larson
EHEllie Hsu
Ellie Hsu
HBHind A. Beydoun
Hind A. Beydoun
MLMichael J. LaMonte
Michael J. LaMonte
LTLesley Trinker
Lesley Trinker
Objective: To examine the association between Life Essential 8 (LE8) and incident T2D in the Women’s Health Initiative (WHI), and to assess whether associations varied by race and ethnicity. Research Design and Methods: Prospective cohort study of 19,403 postmenopausal women enrolled in the WHI without T2D at baseline. Data were analyzed from 1993 through 2024. The LE8 score (range, 0–100), comprising blood glucose, blood lipids, blood pressure, smoking, physical activity, diet, sleep, and body mass index (BMI), categorized as high (80–100), moderate (50–79), and low (0–49) according to AHA definitions. Incident treated T2D was self-reported during follow-up. Cox proportional hazards models estimated hazard ratios (HRs) and 95% CIs for LE8 categories and continuous scores. Results: During a mean follow-up of 16.3 years, 3921 women developed T2D. Compared with the lowest category, women in the highest LE8 category had a 57% lower risk of T2D (HR, 0.43; 95% CI, 0.38–0.49). A 20-point increase in LE8 score was associated with a 43% lower risk (HR, 0.57; 95% CI, 0.54–0.60). Among individual domains, BMI and glucose were most strongly associated with T2D. Subgroup analyses by 20-point increase in LE8 showed greater risk reduction among Hispanic/Latina women (HR, 0.46; 95% CI, 0.41–0.53) compared with non-Hispanic women (HR, 0.58; 95% CI, 0.55–0.62), but no significant association with race was observed. Conclusions: Higher LE8 scores are associated with a reduced risk of T2D in postmenopausal women, supporting LE8 as a useful framework for lifestyle-based diabetes prevention strategies.